PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory Section, Medical Commission Department, Ministry of Public Health, 42 Doha, Qatar.\', \'Biomedical Research Center, Qatar University, 2713 Doha, Qatar.\', \'Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, 2713 Doha, Qatar.\', \'College of Medicine, Member of QU Health, Qatar University, 2713 Doha, Qatar.\', \'Department of Clinical Research, Primary Health Care Centers, 26555 Doha, Qatar.\', \'Department of Pathology, Sidra Medicine, 26999 Doha, Qatar.\', \'Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, 24144 Doha, Qatar.\', \'World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, 24144 Doha, Qatar.\', \'Department of Healthcare Policy and Research, Weill Cornell Medicine, Cornell University, New York, NY 10065, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.52586/4934
?:hasPublicationType
?:journal
  • Frontiers in bioscience (Landmark edition)
is ?:pmid of
?:pmid
?:pmid
  • 34340267
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Can commercial automated immunoassays be utilized to predict neutralizing antibodies after SARS-CoV-2 infection? A comparative study between three different assays.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all